Sunitinib in Advanced Pancreatic Neuroendocrine Tumors Sunitinib in Advanced Pancreatic Neuroendocrine Tumors
New hope for patients with well-differentiated pancreatic neuroendocrine tumors may be close at hand. Therapeutic Advances in Medical Oncology (Source: Medscape Today Headlines)
Barr Confirms Patent Challenge of Razadyne(R) ER Capsules
WOODCLIFF LAKE, N.J., July 6 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE:BRL) today confirmed that Janssen Pharmaceutica N.V., Janssen, L.P., Ortho-McNeil Neurologics, Inc. and Synaptech, Inc. (quot;Plaintiffquot;) filed suit against it and its subsidiary, Barr Laboratories, Inc., relating to the patent protecting Razadyne(R) ER (Galantamine Hydrobromide Extended-Release Capsules), 8 mg, 16... (Source: Drug Newswire)
